Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic - PubMed (original) (raw)
Review
. 2019 Jan 14:19:/books/9783110527872/9783110527872-019/9783110527872-019.xml.
doi: 10.1515/9783110527872-019.
- PMID: 30855114
- DOI: 10.1515/9783110527872-019
Free article
Review
Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic
Dinorah Gambino et al. Met Ions Life Sci. 2019.
Free article
Abstract
Metal compounds seem to be a promising approach in the search of new therapeutic solutions for neglected tropical diseases. In this chapter, efforts in the design of prospective metal-based drugs for the treatment of Chagas disease, human African trypanosomiasis, and leishmaniasis are discussed. Careful selection of the metal center (including organometallic cores) and the types and number of coordinated ligands is essential for controlling the reactivity of the complexes and hence, tuning their biological properties. In a target-based approach, some targets that have been validated for organic antiparasitic compounds are expected to remain targets for metal complexes of these compounds. In addition, specific targets for metal compounds, like parasitic enzymes or DNA, would also be included for these metal complexes leading to potential additive or even synergistic effects between organic ligand and metal ion. However, even though a good number of prospective antiparasitic metal-based drugs have been developed, further systematic efforts are needed for these metal compounds to accomplish the regulatory guidelines that let them reach the different stages of clinical trials.
Similar articles
- Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.
Ravera M, Moreno-Viguri E, Paucar R, Pérez-Silanes S, Gabano E. Ravera M, et al. Eur J Med Chem. 2018 Jul 15;155:459-482. doi: 10.1016/j.ejmech.2018.05.044. Epub 2018 Jun 1. Eur J Med Chem. 2018. PMID: 29908440 Review. - Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D, Mendoza AR, Meléndez CM. Orosco D, et al. Curr Top Med Chem. 2024;24(2):89-108. doi: 10.2174/0115680266256963230921061925. Curr Top Med Chem. 2024. PMID: 37842892 Review. - Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights.
Navarro M, Justo RMS, Delgado GYS, Visbal G. Navarro M, et al. Curr Pharm Des. 2021;27(15):1763-1789. doi: 10.2174/1381612826666201113104633. Curr Pharm Des. 2021. PMID: 33185155 - Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological.
Oliveira JWF, Rocha HAO, de Medeiros WMTQ, Silva MS. Oliveira JWF, et al. Molecules. 2019 Aug 1;24(15):2806. doi: 10.3390/molecules24152806. Molecules. 2019. PMID: 31374887 Free PMC article. Review. - Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
Sánchez-Delgado RA, Anzellotti A. Sánchez-Delgado RA, et al. Mini Rev Med Chem. 2004 Jan;4(1):23-30. doi: 10.2174/1389557043487493. Mini Rev Med Chem. 2004. PMID: 14754440 Review.
Cited by
- Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates.
Holzer I, Desiatkina O, Anghel N, Johns SK, Boubaker G, Hemphill A, Furrer J, Păunescu E. Holzer I, et al. Molecules. 2023 Jan 16;28(2):902. doi: 10.3390/molecules28020902. Molecules. 2023. PMID: 36677958 Free PMC article. - Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria.
Nolan VC, Rafols L, Harrison J, Soldevila-Barreda JJ, Crosatti M, Garton NJ, Wegrzyn M, Timms DL, Seaton CC, Sendron H, Azmanova M, Barry NPE, Pitto-Barry A, Cox JAG. Nolan VC, et al. Curr Res Microb Sci. 2021 Dec 16;3:100099. doi: 10.1016/j.crmicr.2021.100099. eCollection 2022. Curr Res Microb Sci. 2021. PMID: 35059676 Free PMC article. - Metallomics: An Essential Tool for the Study of Potential Antiparasitic Metallodrugs.
Machado I, Gambino D. Machado I, et al. ACS Omega. 2024 Mar 25;9(14):15744-15752. doi: 10.1021/acsomega.3c10200. eCollection 2024 Apr 9. ACS Omega. 2024. PMID: 38617611 Free PMC article. Review. - Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of Trypanosoma cruzi.
Scalese G, Machado I, Salinas G, Pérez-Díaz L, Gambino D. Scalese G, et al. Molecules. 2021 Sep 3;26(17):5375. doi: 10.3390/molecules26175375. Molecules. 2021. PMID: 34500808 Free PMC article. - Multi-target heteroleptic palladium bisphosphonate complexes.
Cipriani M, Rostán S, León I, Li ZH, Gancheff JS, Kemmerling U, Olea Azar C, Etcheverry S, Docampo R, Gambino D, Otero L. Cipriani M, et al. J Biol Inorg Chem. 2020 May;25(3):509-519. doi: 10.1007/s00775-020-01779-y. Epub 2020 Mar 30. J Biol Inorg Chem. 2020. PMID: 32232584
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources